BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 26806465)

  • 1. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
    Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
    Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
    Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
    Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.
    Hua MY; Liu HL; Yang HW; Chen PY; Tsai RY; Huang CY; Tseng IC; Lyu LA; Ma CC; Tang HJ; Yen TC; Wei KC
    Biomaterials; 2011 Jan; 32(2):516-27. PubMed ID: 21030073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
    Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
    Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
    Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
    Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug embedded PVP coated magnetic nanoparticles for targeted killing of breast cancer cells.
    Rose PA; Praseetha PK; Bhagat M; Alexander P; Abdeen S; Chavali M
    Technol Cancer Res Treat; 2013 Oct; 12(5):463-72. PubMed ID: 23547975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.
    Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y
    Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
    Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
    Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
    Prabha G; Raj V
    Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
    Kuo YC; Liang CT
    Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
    Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB
    Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.
    Yang HW; Hua MY; Liu HL; Huang CY; Tsai RY; Lu YJ; Chen JY; Tang HJ; Hsien HY; Chang YS; Yen TC; Chen PY; Wei KC
    Biomaterials; 2011 Sep; 32(27):6523-32. PubMed ID: 21645920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique.
    Dey C; Ghosh A; Ahir M; Ghosh A; Goswami MM
    Chemphyschem; 2018 Nov; 19(21):2872-2878. PubMed ID: 30133086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications.
    Nadeem M; Ahmad M; Akhtar MS; Shaari A; Riaz S; Naseem S; Masood M; Saeed MA
    PLoS One; 2016; 11(6):e0158084. PubMed ID: 27348436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy.
    Scialabba C; Licciardi M; Mauro N; Rocco F; Ceruti M; Giammona G
    Eur J Pharm Biopharm; 2014 Nov; 88(3):695-705. PubMed ID: 25281781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.